MPR Kontakt Icon
Choose language
MPR Suche
MPR Close
Schließen
Zurück

MFDS Ovulation Test Update Supports Planned Pregnancy in Korea

9. July 2026

The Korean market for MFDS ovulation tests continues to evolve as growing numbers of couples take a more planned approach to pregnancy. Responding to this trend, Dong-A Pharmaceutical has introduced the Echeck Goodnews Ovulation Test, an in vitro diagnostic (IVD) medical device designed to provide a more intuitive indication of the ovulation window through a five-level color scale.

The product measures luteinizing hormone (LH) levels in urine to estimate when ovulation is approaching, helping users identify the most fertile period. Unlike conventional ovulation tests that require users to visually compare the darkness of a test line, the new device incorporates a color chart intended to simplify interpretation. Test results are available within approximately five minutes, and the manufacturer states that the device achieves an accuracy of more than 99% when used according to the instructions. Ovulation test devices usually require MFDS certification in order to be approved for import and sale in Korea.

Improved Usability for In Vitro Diagnostic Devices

Ovulation tests are classified as in vitro diagnostic medical devices and play an important role in fertility planning by detecting hormonal changes associated with ovulation. The introduction of a standardized five-level color chart is intended to improve usability by making it easier for consumers to estimate how close they are to ovulation without relying solely on subjective visual interpretation.

According to the manufacturer, reliability can be further enhanced by performing the test at the same time each day, while avoiding the first morning urine sample. Such recommendations are consistent with established testing practices that help produce more consistent results.

Implications for the Korean Medical Device Market

The product launch reflects increasing demand for fertility-related diagnostic solutions as demographic trends continue to influence family planning decisions. Alongside diagnostic testing, healthcare professionals emphasize that successful pregnancy planning also depends on broader health management, including regular exercise, balanced nutrition, and appropriate intake of essential micronutrients.

For women, maintaining sufficient levels of iron and vitamin D may support reproductive health, while zinc and coenzyme Q10 are commonly highlighted for their roles in male reproductive function. Maintaining a healthy body fat percentage is also considered an important factor, as excessive or insufficient body fat can affect hormonal balance and fertility in both women and men.

Manufacturers supplying fertility-related IVD products to the Korean market should ensure compliance with applicable MFDS regulatory requirements, including relevant medical device and in vitro diagnostic regulations, before placing products on the market. Further regulatory information may be available through official MFDS resources and company regulatory updates.

Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.

Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673

Email: info@korea-certification.com

For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.

MPR Author

About the author: Louis Gogger is Managing Director of MPR International GmbH
Publisher: MPR International GmbH

Tel.: +49 69 271 37 69 259

E-Mail: info@korea-certification.com
Web: www.korea-certification.com